How Common Is a Zero Calcium Score?

A zero coronary artery calcium (CAC) score is common, but how common depends heavily on who you are. In screening populations of asymptomatic adults, the majority of people under 50 score zero, while the majority over 65 do not. Across studies of patients presenting with chest pain, roughly half to 60 percent still register a zero. The result is reassuring but not bulletproof, and the story behind it involves age, sex, ethnicity, and a few important caveats about what the scan can and cannot see.

What the Numbers Look Like by Age, Sex, and Race

Among younger adults aged 30 to 45, most people have no detectable coronary calcium at all. A study of this age group found that about three-quarters of white men and roughly 90 percent of white and Black women scored zero, meaning detectable calcium was present in only about a quarter of white men, 16 percent of Black men, 10 percent of white women, and 7 percent of Black women.¹ In other words, a zero score is the norm at that age, especially for women.

As people get older, the picture shifts. Data from a large Japanese cohort showed that detectable calcium in men begins climbing steeply around age 40 and exceeds 25 percent prevalence by about 50. Women follow a similar curve shifted roughly a decade later, with prevalence not crossing 25 percent until around age 60.² By 75 or older, a zero score becomes relatively uncommon, though it still occurs.

Race and ethnicity add another layer. The Multi-Ethnic Study of Atherosclerosis (MESA), which followed thousands of adults from four racial groups, found consistent differences: white men had the highest calcium levels across all ages, with Hispanic men ranking second. Black men had the lowest calcium at younger ages and Chinese men the lowest at older ages. Among women, whites generally had the highest scores and Hispanics the lowest, though the ranking shifted at the oldest ages.³ South Asian adults at low or intermediate estimated risk were also more likely to have a zero score than white adults at the same risk level, though that gap narrowed among high-risk individuals.⁴

What a Zero Score Tells You About Future Heart Events

The practical value of a zero CAC score is its strong negative predictive power. A meta-analysis of patients presenting with chest pain found that among those with stable symptoms, a zero score ruled out obstructive coronary artery disease about 97 percent of the time. For patients with acute chest pain, the figure was roughly 98 percent. The annual rate of major cardiac events among zero-score patients with stable symptoms was about 0.5 percent, and for acute chest pain patients it was around 0.8 percent overall.⁵ A separate meta-analysis of acute chest pain patients put the pooled event rate for a zero score at about 0.8 percent per year for major adverse events and 0.5 percent per year for death or heart attack, compared with roughly 15 percent per year for those with any calcium at all.⁶

Those numbers translate to a simple takeaway: a zero score does not guarantee a clean bill of cardiac health, but it puts you in a low-risk category by a wide margin. For emergency departments evaluating chest pain, a zero calcium score had a sensitivity of about 96 percent for obstructive disease and a negative predictive value of over 99 percent for identifying patients who actually needed a procedure like a stent.⁷

How Long a Zero Score Stays Reassuring

One of the most common follow-up questions is how often to rescan. Researchers have framed this as a “warranty period,” borrowing the language of product guarantees. A large prospective study following nearly 10,000 asymptomatic individuals found that for those at low or intermediate risk, a zero score held up for almost 15 years before their risk profile meaningfully changed.⁸

A more granular MESA analysis put practical rescanning timelines shorter, at roughly 3 to 7 years depending on sex and ethnicity, based on when enough people would have transitioned to detectable calcium to make rescanning worthwhile. That analysis also found that diabetes substantially shortened the warranty period, while smoking and family history had smaller effects. About 19 percent of all coronary events over 10 years happened in people whose last scan was zero before they could be rescanned.⁹ That 19 percent figure is a reminder that a zero score shifts the odds dramatically in your favor but does not eliminate risk entirely.

When a Zero Score Can Be Misleading

The Agatston scoring method, which is the standard technique used worldwide, detects calcium deposits in artery walls. What it does not detect is soft, non-calcified plaque. These fatty deposits have not yet hardened, but they can still narrow arteries and, in some cases, rupture and trigger a heart attack. A systematic review pooling data from over 37,000 patients with a zero calcium score found that about 10 percent had some form of non-calcified plaque, and roughly 1 percent had obstructive non-calcified plaque. Being male was the strongest predictor of having these hidden plaques, followed by diabetes and high blood pressure.¹⁰

A smaller study of patients who had CT angiography despite a zero calcium score identified plaques in 82 coronary arteries across 66 patients, with age over 55 and a body mass index over 27 emerging as independent risk factors for those plaques.¹¹ The practical message is that a zero score is most reassuring in younger, lower-risk individuals and loses some of its power in older adults or those with metabolic risk factors, where soft plaque becomes more likely.

Younger Patients With Heart Disease Frequently Score Zero

The calcium score’s blind spot for soft plaque is especially relevant in younger patients. A study of symptomatic patients across age groups found that among those under 40 with confirmed obstructive coronary disease, 58 percent had a calcium score of zero. In the 40-to-49 age bracket, about a third of people with real blockages still scored zero. Women were even more likely to have this mismatch: 74 percent of women under 40 with obstructive disease had no detectable calcium, and nearly half of those aged 40 to 49.¹² The rate dropped with age, falling to about 5 percent for patients 70 and older, because older plaques are far more likely to contain calcium. This is one reason clinicians are cautious about using a zero calcium score alone to rule out heart disease in young adults with symptoms.

Technical Limits of the Scoring Method

The Agatston method itself has built-in thresholds that can miss very small or less dense calcium deposits. The standard algorithm requires a minimum area of 1 square millimeter and a density of at least 130 Hounsfield units before it registers anything. One study compared baseline scans in patients who initially scored zero but later developed detectable calcium. By lowering the size threshold and slightly reducing the density cutoff to 120 Hounsfield units, researchers found 34 true-positive lesions that the standard algorithm had missed, with only a small increase in false positives.¹³ Another study using thinner image slices (0.5 millimeters instead of the standard 3 millimeters) detected over 20 percent more patients with subclinical atherosclerosis than the standard scan.¹⁴ These findings suggest that some people walking around with a “zero” may have trace amounts of calcium that current clinical scanners are simply too coarse to catch.

How a Zero Score Affects Medication Decisions

For people whose estimated 10-year cardiovascular risk falls in the intermediate zone (where guidelines suggest statins might help but are not mandatory), a zero calcium score can tip the decision away from starting medication. Registry data have shown that patients with a zero score receive minimal near-term benefit from statin therapy, while people with detectable calcium see a clear reduction in events.¹⁵ In the MESA cohort, adding the calcium score to standard risk equations improved the ability to correctly classify who should and should not be on a statin more than any single risk-enhancing factor like family history or inflammatory markers.¹⁶

The aspirin question is even sharper. MESA data showed that for people with a zero score, the estimated number of patients you would need to treat with aspirin for five years to prevent one heart event was vastly higher than the number who would suffer a major bleed from the aspirin itself. In plain terms, aspirin caused more harm than good in the zero-calcium group.¹⁷ A separate MESA analysis reinforced that among individuals at low or intermediate 10-year risk, aspirin was estimated to result in net harm regardless of calcium status; only the highest-risk group saw net benefit.¹⁸ These findings have contributed to the broader shift away from routine aspirin for primary prevention, with the calcium score serving as one piece of evidence that makes the case for holding off.

Diabetes, Family History, and Other High-Risk Situations

Diabetes is the condition that complicates a zero score the most. In one cohort of nearly 2,800 people with diabetes, 17 percent had a zero calcium score. That is considerably less than the general population of the same age, but it is not rare. Among those zero-score diabetic patients, 29 percent still had some non-calcified plaque visible on CT angiography, meaning nearly a third were not plaque-free despite the clean calcium scan.¹⁹ Still, MESA data showed that even among people with diabetes in the highest traditional risk category, those with a zero calcium score had substantially lower event rates than diabetics with any calcium, with the heart disease event rate running about 4.7 per 1,000 person-years compared with much higher rates for those with elevated scores.²⁰ A zero score in a person with diabetes is still good news; it is just not quite as clean a bill of health as the same score in someone without diabetes.

Family history of premature heart disease is another concern people bring to this test. Among MESA participants with a zero calcium score, those with a positive family history had about 70 percent higher odds of a cardiovascular event over 10 years compared to those without a family history. Annual event rates were low in both groups (0.44 percent versus 0.26 percent for cardiovascular events), but the relative difference was real and persisted after adjusting for age and sex.²¹ So if heart disease runs in your family, a zero score still moves you into a better risk category, but it does not erase the family history signal entirely.

A Zero Score and Broader Aging

Beyond predicting heart attacks, a zero calcium score appears to track with healthier aging overall. In adults 75 and older enrolled in the Atherosclerosis Risk in Communities Study, those with a zero score were much less likely to show signs of peripheral artery disease, arterial stiffness, or reduced lung function compared to people with very high calcium scores. The high-calcium group was also more likely to have impaired physical function and weaker grip strength.²² This suggests the calcium score reflects something broader about vascular health and biological age, not just the state of the coronary arteries.

A MESA analysis tracking who maintained a zero score over time found that about 55 percent of initially zero-score participants stayed at zero through follow-up. These “healthy arterial agers” were more likely to be younger, female, and to carry fewer traditional risk factors. Interestingly, the study found no significant association between classic healthy-lifestyle variables like physical activity, diet quality, and never smoking and maintaining a zero score, once conventional risk factors were accounted for.²³ That does not mean lifestyle does not matter for heart health broadly, but it does hint that whether your arteries calcify involves genetic and metabolic pathways that are not fully captured by the behaviors we usually focus on.

How Knowing Your Score Changes What You Do

People who learn they have a zero score tend to relax, sometimes too much. One study found that statin compliance was lowest among patients with a zero score, at about 27 percent, compared with nearly 59 percent among those with the highest calcium scores. The same pattern held for aspirin use, dietary changes, and exercise: all were lowest in the zero-score group and rose stepwise with higher scores.²⁴ A separate study confirmed the trend: only 29 percent of zero-score patients started aspirin, compared with 63 percent of those with scores of 400 or higher, and both dietary improvement and exercise initiation followed similar gradients.²⁵

This creates a paradox. For many people with a zero score, backing off a statin is medically reasonable since the near-term benefit is small. But the motivational deflation can extend to behaviors where the benefit is not small, like staying active and eating well. Clinicians sometimes struggle with messaging here: the point of reporting a zero score is not that you can stop caring about cardiovascular health, but that you have more room to manage risk through lifestyle rather than medication.

Is the Scan Worth the Cost?

A CAC scan typically costs between $75 and $300 out of pocket, depending on location, and most insurance plans in the United States do not cover it for asymptomatic screening. An economic analysis using MESA data found that screening all intermediate-risk patients and treating those with any detectable calcium was generally the least costly and most effective strategy compared with either treating everyone or using older cholesterol guidelines, as long as the scan cost stayed below about $150. The break-even point where calcium scoring lost its cost advantage was around $235 per scan.²⁶ A Canadian analysis reached a similar conclusion: calcium-guided statin prescribing was borderline cost-neutral over five years and clearly cost-effective over 10 years for intermediate-risk patients.²⁷ The savings come largely from the zero-score group, because identifying them allows you to safely defer statin therapy for years.

Incidental Findings on the Scan

One thing people rarely expect when they go in for a calcium score is that the scan images a slice of your chest, not just your heart. That means the radiologist may spot something unrelated to coronary arteries. In one study of nearly 2,900 patients, about 8.5 percent had a potentially significant incidental finding, most commonly in the lungs, with a follow-up procedure recommended for about two-thirds of those findings.²⁸ A smaller study found extracardiac abnormalities in 43 percent of patients, though only about half of those were considered clinically significant, and the majority were previously unknown.²⁹ This is a double-edged sword: sometimes the scan catches an early lung nodule that matters, but other times it triggers a chain of follow-up imaging and biopsies for something that turns out to be harmless. It is worth knowing before you go in that the test may raise questions beyond your coronary arteries.

Where Calcium Scoring Fits Alongside Other Tests

Clinicians and patients sometimes wonder whether blood markers like C-reactive protein (CRP) can substitute for or add to the calcium score. In the JUPITER trial population, the presence of coronary calcium was associated with roughly four times the risk of coronary heart disease events, while high-sensitivity CRP was not independently associated after adjusting for other factors.³⁰ An earlier study of non-diabetic individuals found that calcium and CRP were somewhat complementary: people with both high calcium and elevated CRP had up to six to seven times the risk of a cardiovascular event compared with people who had moderate calcium but low CRP.³¹ The upshot is that while CRP captures systemic inflammation, the calcium score captures the actual structural state of your arteries, and neither fully replaces the other. For the person whose question is “do I have early atherosclerosis right now,” the calcium scan answers that more directly than any blood test can.